Your browser doesn't support javascript.
loading
Observation versus late reintroduction of letrozole as adjuvant endocrine therapy for hormone receptor-positive breast cancer (ANZ0501 LATER): an open-label randomised, controlled trial.
Zdenkowski, N; Forbes, J F; Boyle, F M; Kannourakis, G; Gill, P G; Bayliss, E; Saunders, C; Della-Fiorentina, S; Kling, N; Campbell, I; Mann, G B; Coates, A S; Gebski, V; Davies, L; Thornton, R; Reaby, L; Cuzick, J; Green, M.
Afiliação
  • Zdenkowski N; Australia and New Zealand Breast Cancer Trials Group, Waratah School of Medicine and Public Health, University of Newcastle, Callaghan, Australia nicholas.zdenkowski@anzbctg.org.
  • Forbes JF; Australia and New Zealand Breast Cancer Trials Group, Waratah School of Medicine and Public Health, University of Newcastle, Callaghan, Australia.
  • Boyle FM; Australia and New Zealand Breast Cancer Trials Group, Waratah School of Medicine and Public Health, University of Newcastle, Callaghan, Australia Patricia Ritchie Centre for Cancer Care and Research, North Sydney.
  • Kannourakis G; Ballarat Oncology and Haematology, Wendouree.
  • Gill PG; Department of Surgery, Royal Adelaide Hospital, Adelaide.
  • Bayliss E; Department of Medical Oncology, Royal Perth Hospital, Perth.
  • Saunders C; School of Surgery, University of Western Australia, Crawley.
  • Della-Fiorentina S; Southern Highlands Cancer Centre, Bowral.
  • Kling N; Department of Surgery, St John of God Hospital, Bunbury, Australia.
  • Campbell I; Breast Care Centre, Waikato Hospital, Hamilton, New Zealand.
  • Mann GB; Department of Surgery, The University of Melbourne, The Royal Melbourne Hospital, Parkville.
  • Coates AS; Australia and New Zealand Breast Cancer Trials Group, Waratah National Health and Medical Research Council Clinical Trials Centre, University of Sydney, Camperdown, Australia.
  • Gebski V; National Health and Medical Research Council Clinical Trials Centre, University of Sydney, Camperdown, Australia.
  • Davies L; National Health and Medical Research Council Clinical Trials Centre, University of Sydney, Camperdown, Australia.
  • Thornton R; Australia and New Zealand Breast Cancer Trials Group, Waratah.
  • Reaby L; Australia and New Zealand Breast Cancer Trials Group, Waratah.
  • Cuzick J; Centre for Cancer Prevention, Wolfson Institute of Preventive Medicine, Queen Mary University of London, London, UK.
  • Green M; Department of Surgery, The University of Melbourne, The Royal Melbourne Hospital, Parkville.
Ann Oncol ; 27(5): 806-12, 2016 05.
Article em En | MEDLINE | ID: mdl-26861603
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Triazóis / Neoplasias da Mama / Antineoplásicos Hormonais / Recidiva Local de Neoplasia / Nitrilas Tipo de estudo: Clinical_trials Limite: Aged / Female / Humans / Middle aged País/Região como assunto: Oceania Idioma: En Revista: Ann Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Austrália
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Triazóis / Neoplasias da Mama / Antineoplásicos Hormonais / Recidiva Local de Neoplasia / Nitrilas Tipo de estudo: Clinical_trials Limite: Aged / Female / Humans / Middle aged País/Região como assunto: Oceania Idioma: En Revista: Ann Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Austrália